Tricky FDA Debate: Should a Risky Drug Be Approved Again?

dc.creator	Mathews, Anna Wilde	en
dc.creator	Westphal, Sylvia Pagan	en
dc.date.accessioned	2016-01-08T23:34:07Z	en
dc.date.available	2016-01-08T23:34:07Z	en
dc.date.created	2006-02-24	en
dc.date.issued	2006-02-24	en
dc.identifier.bibliographicCitation	Wall Street Journal 2006 February 24; p. B1, B4	en
dc.identifier.uri	http://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Tricky+FDA+debate:+should+a+risky+drug+be+approved+again?&title=Wall+Street+Journal&date=2006-02&au=Mathews,+Anna+Wilde;+Westphal,+Sylvia+Pagan	en
dc.identifier.uri	http://hdl.handle.net/10822/974430	en
dc.format	News Article	en
dc.language	en	en
dc.source	eweb:294162	en
dc.subject.classification	Drugs and Drug Industry	en
dc.title	Tricky FDA Debate: Should a Risky Drug Be Approved Again?	en
dc.provenance	Citation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.	en
dc.provenance	Citation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.	en

Related items